DIMENSIONAL FUND ADVISORS LP

Position in GRAL — GRAIL, Inc.

CIK 354204 AUSTIN, TX

Position in GRAL

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$21,119,029

+$2,563,720 QoQ

Shares Held

408,650

+88.5% QoQ

Ownership

0.952%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 89.40193319466536.ToString("F0")% Shared 6.810473510338921.ToString("F0")% None 3.787593294995718.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $4,738,083,100 across 33 Diagnostics & Research names. GRAL ranks #23 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	1,689,790	$830,582,476
2	DHR	Danaher Corp /De/	2,645,911	$501,664,724
3	DGX	Quest Diagnostics Inc	1,949,535	$382,069,866
4	LH	Labcorp Holdings Inc.	1,332,775	$355,597,695
5	IDXX	Idexx Laboratories Inc /De	573,332	$322,149,515
6	CRL	Charles River Laboratories International, Inc.	1,652,484	$285,053,489
7	IQV	Iqvia Holdings Inc.	1,657,696	$282,703,474
8	RVTY	Revvity, Inc.	2,917,953	$255,641,860

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,119,029	408,650	+88.5%	Shares	Sole	2026-05-07
2025-12-31	$18,555,309	216,793	+364.7%	Shares	Sole	2026-02-12
2025-09-30	$2,758,354	46,649	-2.7%	Shares	Sole	2025-11-12
2025-06-30	$2,464,249	47,924	+0.0%	Shares	Sole	2025-08-12
2025-03-31	$1,223,646	47,911	-0.5%	Shares	Sole	2025-05-13
2024-12-31	$859,512	48,152	-0.2%	Shares	Sole	2025-02-13
2024-09-30	$664,124	48,265	-5.1%	Shares	Sole	2024-11-07
2024-06-30	$781,885	50,871	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.